Summary
The activity of kininase II in crude human sperm was measured continuously by measuring the hydrolysis of a blocked tripeptide 3-(2- furylacryloyl)-L- phenylalanyl-glycl-glycine (1 mmol/1). Mean seminal plasma activity was 335±6l U/g protein; the Km was 0.7 mmol/1; pH optimum was 8.8 in a 50 mmol/1 HEPES buffer and the chloride optimum was 300 mmol/1. This male genital tract enzyme is inhibited by several kininase II inhibitors. Captopril (SQ 14225) showed IC50 = 1.6 × 10−8 mol/1, with a competitive pattern (Ki = 7.3 × 10−9). 3-(Mercaptomethy1)-oxo- piperidineacetic acid showed the same kind of inhibition with an IC50 = 1.8 × 10−6 mol/1 (Ki = 6.8 × 10−7 mol/1). Enalapril diacid was the most potent inhibitor and had an IC50 of 4.1 × 10−9 mol/1 and showed a mixed competitive and non-competitive inhibition (Ki = 10−9 mol/Ki’ = 9.5 × 10−10 mol/1). These in vitro inhibition data suggest that, in vivo, such drugs may effect the function of kininase II in the male reproductive system. The observed 50% inhibition constants are comparable to those observed in lung enzyme suggesting similar kinetic properties.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
M. A. Hollinger, Serum angiotensin-converting enzyme. Status report on its diagnostic significance in pulmonary disease, Chest, 83: 589–590, (1983).
D. Depierre, J. P. Bargetzi, and M. Roth, Dipeptidyl carboxypeptidase from human seminal sperm, Biochim. Biophys. Acta, 523: 469–476, (1978).
S. Kaneko, & C. Moriwaki, Studies on dipeptidyl carboxypeptddase in the male reproductive organs; its biological and pathological status J. Pharm. Dyn., 4: 175–183, (1981).
S. Kaneko, & C. Moriwaki, Effects of kinins and dipeptidyl carboxypeptidase on the motility of highly washed human sperm, J. Pharm. Dyn., 4: 443–450, (1981).
M. Horiuchi, K. I. Fukumura, T. Terashima, & T. Iso, Method for determination of angiotensin-converting enzyme activity in blood and tissue by high performance liquid chromatography, J. Chromatogr. 233: 123–130, (1982).
M. A. Ondetti, B. Rubin, & D. W. Cushman, Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents, Science, 166: 441–444, (1977).
S. Klutcho, M. L. Hoefle, R. D. Smith, et al., Synthhsis and angio-tensin-converting enzyme inhibitory activity of 3-(mercaptomethyl)- 2-oxo-l-pyrrolidineacetic acids and 3-(mercaptomethyl)-2-oxo-l- piperidineacetic acids, J. Med. Chem., 24: 104–109, (1980).
A. A. Patchett, E. Harris, E. W. Tristram, et al., A new class of angiotensin-converting enzyme inhibitors, Nature, 288: 280–283, (1980).
R. J. Klauser, C. J. G. Robinson, D. V. Marinkovic, & E. G. Erdos, Inhibition of human peptidyl dipeptidase (angiotensin-I converting enzyme: kininase II) by human serum albumin and its fragments, Hypertension, 1: 281–286, (1979).
B. Holmquist, P. Biinning, & J. F. Riordan, A continuous spectrophotometry assay for angiotensin converting enzyme, Anal. Biochem., 95: 540–548, (1979).
R. Eisenthal, & A. Cornish-Bowden, The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters, Biochem. J., 139: 715–720, (1974).
G. L. Atkins, & I. A. Nimmo, Current trends in the estimation of Michaelis-Menten parameters, Anal. Biochem., 104: 1–9, (1980).
A. Cornish-Bowden, Principles of enzyme kinetics. Inhibitors and activators, Butterworths, London, p. 52, (1976).
R. B. Loftfield, & E. A. Eigner, Molecular order of participation of inhibitors (or activators) in biological systems, Science, 164: 305–308, (1969).
H. M. Neels, S. L. Scharpi, M. E. van Sande, & G. A. Fonteyne, Single-reagent micro centrifugal assay for antiotensin converting enzyme, Clin. Chem., 30: 163–164, (1984).
D. W. Cushman, & H. S. Cheung, Concentrations of angiotensin converting enzyme in tissues of the rat, Biochim. Biophys. Acta, 250: 261–265, (1971).
H. M. Neels, S. L. Scharpe, G. A. Fonteyne, et al., Fluorometric assay for angiotensin converting enzyme in human serum by centrifugal analysis, Clin. Chim. Acta, 141: 281–286, (1984).
H. M. Neels, S. L. Scharpe, M. E. Van Sande, et al., Improved micro-method for assay of serum angiotensin converting enzyme, Clin. Chem., 28: 1352–1355, (1982).
S. Ronca-Testoni, Direct spectrophotometric assay for angiotensin converting enzyme in serum, Clin. Chem., 29: 1093–1096, (1983).
D. W. Cushman, H. S. Cheung, E. F. Sabo, & M. A. Ondetti, Design of potent competitive inhibitors of angiotensin converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl aminoacids, Biochem., 16: 5484–5491, (1977).
H. Gravas, J. Biollaz, B. Waeber, et al., Effects of the oral angiotensin converting enzyme inhibitor MK-421 in human hypertension, Clin. Sci., 6: 281s–283s, (1981).
H. Sato, Components of kallikrein kinin system and treatment of male infertility, Keio J. Med., 29: 19–38, (1980).
C. Gronhagen-Riska, & F. Fyhrquist, Purification of human lung angiotensin converting snzyme, Scand. J. Clin. Lab. Invest., 40: 711–719, (1980).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
van Sande, M., Neels, H., Scharpé, S., Holmquist, B. (1986). Kininase II of Human Seminal Fluid: Kinetics and Inhibition. In: Greenbaum, L.M., Margolius, H.S. (eds) Kinins IV. Advances in Experimental Medicine and Biology, vol 198A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5143-6_63
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5143-6_63
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5145-0
Online ISBN: 978-1-4684-5143-6
eBook Packages: Springer Book Archive